Shellee A Grim

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi request reprint Tenofovir disoproxil fumarate
    Shellee A Grim
    University of Kentucky, Lexington, KY 40536 0293, USA
    Ann Pharmacother 37:849-59. 2003
  2. ncbi request reprint Correlation of levetiracetam concentrations between serum and saliva
    Shellee A Grim
    University of Kentucky Chandler Medical Center, Lexington, USA
    Ther Drug Monit 25:61-6. 2003
  3. ncbi request reprint Correlation of lamotrigine concentrations between serum and saliva
    Melody Ryan
    University of Kentucky Chandler Medical Center, Lexington 40536 0293, USA
    Pharmacotherapy 23:1550-7. 2003
  4. ncbi request reprint Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD)
    Michael V Miles
    Department of Pediatrics, University of Cincinnati Medical Center, and Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Ther Drug Monit 26:300-4. 2004
  5. ncbi request reprint Topiramate concentration in saliva: an alternative to serum monitoring
    Michael V Miles
    Pathology and Laboratory Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Pediatr Neurol 29:143-7. 2003
  6. ncbi request reprint Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus
    Shellee A Grim
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Pharmacotherapy 25:253-64. 2005

Detail Information

Publications6

  1. ncbi request reprint Tenofovir disoproxil fumarate
    Shellee A Grim
    University of Kentucky, Lexington, KY 40536 0293, USA
    Ann Pharmacother 37:849-59. 2003
    ..To review the pharmacology, virology, pharmacokinetics, efficacy, safety, resistance profile, and clinical use of tenofovir disoproxil fumarate...
  2. ncbi request reprint Correlation of levetiracetam concentrations between serum and saliva
    Shellee A Grim
    University of Kentucky Chandler Medical Center, Lexington, USA
    Ther Drug Monit 25:61-6. 2003
    ..No published data exist for levetiracetam (LEV) to the authors' knowledge. This study's objective is to determine the correlation between LEV serum and saliva concentrations...
  3. ncbi request reprint Correlation of lamotrigine concentrations between serum and saliva
    Melody Ryan
    University of Kentucky Chandler Medical Center, Lexington 40536 0293, USA
    Pharmacotherapy 23:1550-7. 2003
    ..To compare the relationship between serum and salivary concentrations of lamotrigine in pediatric and adult epilepsy populations...
  4. ncbi request reprint Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD)
    Michael V Miles
    Department of Pediatrics, University of Cincinnati Medical Center, and Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Ther Drug Monit 26:300-4. 2004
    ..It is also recommended to avoid saliva collection within 8 hours after OXC dosing to allow complete absorption and transformation of the parent drug...
  5. ncbi request reprint Topiramate concentration in saliva: an alternative to serum monitoring
    Michael V Miles
    Pathology and Laboratory Medicine, Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio 45229, USA
    Pediatr Neurol 29:143-7. 2003
    ..8% +/- 12.1% (range 62.9% to 112.7%). The results of this study support the use of saliva as a viable alternative to serum for monitoring topiramate therapy. Topiramate concentration in saliva: an alternative to serum monitoring...
  6. ncbi request reprint Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus
    Shellee A Grim
    Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    Pharmacotherapy 25:253-64. 2005
    ..To review available data regarding the efficacy of trimethoprim-sulfamethoxazole (TMP-SMX) for the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA)...